Clinical Trial Update: Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating posaconazole plus PD-1 inhibitors and chemotherapy versus PD-1 inhibitors and chemotherapy in triple-negative breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• PD-1 inhibitors
• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING